Cash and Equivalents Analysis
Cash or Cash Equivalents are the most liquid of all assets found on company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
| = |
| = |
About Cash and Equivalents
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually 3 months).
In accordance with recently published financial statements Bharat Immunologicals Biologicals Corp Ltd has 152.27 M in Cash and Equivalents. This is much higher than that of the sector, and significantly higher than that of Cash and Equivalents industry, The Cash and Equivalents for all stocks is over 1000% lower than the firm.
Bharat Immunologicals Fundamental Drivers Relationships
Bharat Immunologicals Biologicals Corp Ltd is number one stock in price to earning category among related companies. It is rated below average
in total debt category among related companies making up about 2,700,532
of Total Debt per Price to Earning.